Open AccessInvestigation of the Possibility of Using Serum Ischemia Modified Albumin (IMA) as a Novel and Early Marker of the Extent of Oxidative Stress Induced by Various Tobacco Products
Author(s) -
Gothe Pr,
Maji Jose,
Pai Vr,
Sindhu Harish,
Jyothi M. P. D’souza,
Vishnudas Prabhu
Publication year - 2015
Publication title -
journal of clinical and diagnostic research
Language(s) - English
Resource type - Journals
eISSN - 2249-782X
pISSN - 0973-709X
DOI - 10.7860/jcdr/2015/13928.6763
Subject(s) - ischemia modified albumin , oxidative stress , medicine , albumin , biomarker , serum albumin , ischemia , myocardial ischemia , biochemistry , chemistry
Ischemia Modified Albumin (IMA) is an altered serum albumin that forms under the conditions of oxidative stress and is considered as a biomarker of cardiac ischemia. The objective of this study was to evaluate the ischemia modified albumin (IMA) in the serum of the individuals with different types of tobacco habits in order to investigate the possibility of using this as a biomarker for the oxidative stress induced by the tobacco products.